Back to top

Akebia Reports Positive Interim VOICE Trial Results

An update from Akebia Therapeutics ( ($AKBA) ) is now available. On June 30, 2026, Akebia Therapeutics and U.S. Renal Care reported interim results...

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

Akebia Therapeutics, Inc. (AKBA)